Europes knowledge-based bio-economy (KBBE)

Dr Ioannis EconomidisResearch Directorate-GeneralEuropean Commission DG RTD-E Biotechnology, Agriculture and Food

Towards 3 % of GDP

The R & D spend as a percentage of GDP is an EU-wide issue. The average in 2000 was 1.8 % of GDP across Europe, compared to 2.9 % in Japan and 2.7 % in the US. Major steps are required in the EU to meet the Lisbon target of 3 % by 2010.

The Bio-Economy The term bio-economy includes all industries and economic sectors that produce, manage and otherwise exploit biological resources (e.g. agriculture, food, forestry, fisheries and other bio-based industries);The European bio-economy has an approximate market size of over 1.5 trillion, employing more than 22 million people

* estimated to be around 100-160 million by 2010

WHITE BIOTECHCLEAN BIOPROCESSESRAW MATERIALS/WASTE

THE EUROPEAN KNOWLEDGE-BASED BIOECONOMY

SUSTAINABLE MANAGEMENT OF BIOLOGICAL RESOURCES(LAND, FOREST, MARINE)

SAFE HEALTHY & DIVERSE FOOD SUPPLYFork to Farm

CONSUMER CHOICE

BIOBASEDMATERIALSFOR HEALTHINDUSTRY& ENERGY

GREEN / BLUE BIOTECHOPTIMISED RAW MATERIALS

PRODUCTION

PROCESSING

TRACEABILITY SYSTEMSADVANCED FOOD TECHNOLOGIES

LOW INPUT FARMING - BIODIVERSITY ANIMAL HEALTH - RURAL DEVT.

NUTRITION (nutrigenomics) - PATHOGENS CONTAMINANTS - ALLERGENS

STABILITY - BIODEGRADABILITY FUNCTIONALITY (Chirality)

The Knowledge-Base Life Sciences and Biotechnology in convergence with other technologies..,

provides the knowledge-base for the sustainable management, production and use of biological resources

provides new, safe, affordable and eco-efficient products

supports competitiveness and sustainability of major European industries

Examples: Advances in diagnostics have increased food safety and control of animal diseases (foot and mouth; BSE) Use of enzymes in industrial and household processes (washing powder), and in food production, have strongly reduced energy/water consumption and led to new functional foods.

Exponential increase in the amount of experimental data

Long before we decide to stop using fossil fuels, costs will have already made the decision for us KBBE the major drivers: Sustainability and security of energy supply

KBBE the major drivers: Sustainability and security of food supply Cereals : growth of world demand2004 STOCKS are equivalent to 2 MONTHS consumption!

The KBBE value chain Existing & New Bio-fuels Bulk Chemicals Bio-polymers

Bio-materials Bio-specialities

Standardised Feedstocks:

(Carbohydrates,Proteins, oils, Ligno-cellulosics)

RenewableFeedstocksBioprocessesBulkFineFossil resources

Bio-refineriesWood, Crops, Grasses Forestry or Agricultural Residues Animal or Municipal WasteHeat, Electricity, Fuels Bulk and fine Chemicals Biological raw Materials Food, Feed, FibreBiochemical or Thermo-chemical ConversionWill be supported in two FP7 Thematic Priorities:Food, agriculture and bio-technology and Energy

Poly Lactic Acid (PLA):Bio-plastic made from corn (2003)Blair factory, Nebraska, USA : 140.000 t/year

Industrial Biotechnology is for real Large scale products of Industrial Biotechnology :

Bio-ethanol : 30 million t/year Isoglucose : 15 million t/yearGlutamate : 1.5 million t/yearCitric acid : 1 million t/yearLactic acid : 250.000 t/yearAcrylamide : 200.000 t/year Antibiotics : 30.000 t/year

SUPPLY AND DEMAND CHAIN INHIBITORS IN INDUSTRIAL BIOTECHNOLOGY

In the supply chain the most serious inhibitors identified are: The need for reliable, large-scale supply of raw materials; Proven, full-scale capabilities of the biorefinery to process raw materials into products, and utilise biomass waste for energy generation; Bio-manufacturing is under-developed compared to other manufacturing industries; The education and training of the managerial elite to run a global industry.

SUPPLY AND DEMAND CHAIN INHIBITORS IN INDUSTRIAL BIOTECHNOLOGYOn the demand chain side, the issues are: The ever-present need for innovation, and how to finance it; How to grow the many SMEs in the business; Need for incentives to make industrial biotechnology products more attractive and cost-competitive: green credentials are not enough.

Knowledge Based Bio-Economy:European assets European bio-economy cannot compete on a global level by delivering only basic agricultural commodities, but needs to build on European strengths:excellent science, technology and industry base to deliver innovations;world leader in industrial enzymes and fermentations;world leader in innovative food technologies and products;strong in innovative animal breeding technologies;strong chemical and manufacturing industry base.many more farmers in new EU Member States

The presence of SMEsThe industrial biotechnology industry has expanded rapidly in the last decade, and is characterised by a large presence of SMEs that rely heavily on R & D. A great many of these have no products on the market, and have few visible assets. Getting long-term commitment of large sums of money from the investor community is a demand chain inhibitor.

The presence of SMEsthe SMEs have proportionately less time to educate their markets for new products. The business model whereby the SMEs, often from an academic origin, form strategic alliances with large established companies to share financial risk has emerged as the dominant model for the small industrial biotechnology company. Global governmental incentives are also being deployed and new ones being investigated, to improve the demand for their products.

Knowledge Based Bio-Economy:How to make it happen! Policy-makers, governments, industry, public and private research bodies, civil society to recognise that life science and biotechnology potential has to be carefully nurtured if it is to continue to grow;Establish a regulatory, institutional and societal environment supportive of the bio-economy;Demonstrate clear benefits for the consumer and the environment;

Knowledge Based Bio-Economy:How to make it happen!Incentives to exploit its benefits in terms of competitiveness, environmental compatibility and potential for rural development; Participants in the value chains farmers, industry, regulators and consumers need to pull together to make the bio-economy work.

Knowledge Based Bio-Economy: A complex policy environment! directly relevant: Research & Innovation; Common Agricultural Policy; Common Fisheries Policy; Forestry Strategy; agriculture and trade issues; Food safety regulations; Community Animal Health Policy; Environment and Health Strategies, Competitiveness; Consumer ; Regional and Energy (biomass) policies.

others:transport, environment and biodiversity (climate change, waste, biodiversity,) education and training, employment, internal market (data protection, IPR), European neighbourhood policy;

Life Sciences and Biotechnology A Strategy for EuropeCOM(2002)27 - January 2002

How can Europe best attract the human, industrial and financial resources to develop and apply these technologies to meet societys needs and increase its competitiveness?

How can Europe deliver effective, credible and responsible policies, which deliver the confidence and support of its citizens?

How can Europe best respond to the global challenges, develop its domestic policies with a clear international perspective and act internationally to pursue its interests?

Biofuels in the European UnionA VISION FOR 2030 AND BEYOND

Biofuels Research Advisory Council

VISION

By 2030, the European Union covers as much as one fourth of its road transport fuel needs by clean and CO2-efficient biofuels.

A substantial part is provided by a competitive European industry. This significantly decreases the EU fossil fuel import dependence.

Biofuels are produced using sustainable and innovative technologies; these create opportunities for biomass providers, biofuel producers and the automotive industry.

European Parliament resolution on the promotion of crops for non-food purposes A future for non-food crops

Stresses the importance of increasing the support for research and development in non-food crop technologyStresses the need to carry out research to explore the economic, ecological and technical factors involved in selecting suitable crops Stresses the need for the integration of national research, development and testing of bio-materials at a EU level, particularly with regards to the establishment of an EU-wide research programme on technology for the conversion of biomass into energy, fuel and chemicals

European Parliament resolution on the promotion of crops for non-food purposes A future for non-food cropsCalls for funding for research and rural development to be increasingly directed towards the more efficient and extensive use of organic waste from farming and forestry Calls for increased research funding for new economically efficient and sustainable technologies

Knowledge Based Bio-Economy:The role of research Focus on sustainable management, production and use of biological resources, through life sciences and biotechnology and convergence with other technologies; Realise opportunities (healthier food; cleaner bioproducts/-processes) and address challenges (increasing demand for bioresources);Technology platforms and other stakeholders fora for reflection on and development of research policy; Support to formulation and implementation of policies and regulations.

Research supporting the KBBE: Where are we in Europe?Up to nowCreation of 7 industry-led strategic stakeholder groups (Technology Platforms) relevant to the KBBEA number of relevant networks of national funding agencies developing joint R&D programmes (ERA-NETs) Stakeholder conference (Sep 2005)

The futureA coherent R&D programme within the seventh EU research framework programme (2006-2013) bringing together food, agricultural and biotechnology research to support the KBBEEC-US activity in the area of plant based bio-products

Technology Platforms:Overall ConceptFramework to unite stakeholders around:A common VISION for the technology concernedDefinition of a STRATEGIC RESEARCH AGENDA (SRA)IMPLEMENTATION of the SRA

Wide range of committed companies/organisations

Plants for the FutureBiofuels TPInnovative and sustainableuse of forest resourcesFood for LifeCollaboration with related TPs Building the KBBENon -Food Value ChainFood Value Chain

BelgiumBIPIB RT Chemistry and BiotechNetherlandsKluyver CentreB-BASIC NIIBAustriaKplusUKPro-Bio FaradayCoEBio3GermanyBioProduktionIB platformBaltic regionInst. for Sust. Ind.SwedenIB ForumFinlandIB ForumSwitzerlandWP IB KBBE activities in Member StatesDenmark SD projectFranceAgrice Ple Comp.

European attitudes to six applications of biotechnology

notes

charts of means are based on excluding all DKs for both 96 and 99

in other words it is the means score on a -2 -1 +1 +2 scale for each application

europe99chart

1.2607607929-0.03837875810.89421011730.9610535456

1.13307089190.26749494570.72047002050.7780458999

0.99060534260.22768046920.6683061520.6458870926

0.83754782820.51822427920.32400923520.4326060245

0.50097421220.45852433720.20261684350.0515809058

0.18120906880.6055891229-0.2237605853-0.2252341645

0.02798481260.727883696-0.1432793679-0.3693878275

Positive attitude

Negative attitude

Use

Risk

Acceptable

Encourage

Application

EUROPEAN ATTITUDES TO SEVEN APPLICATIONS OF BIOTECHNOLOGY: 1999

europe02chart

0.86789474510.02553600720.5416902110.5993294196

0.71969517720.35828444370.28668278130.4217100103

0.46495009630.09588906620.29876061930.2145023388

0.431858720.4038858890.02126258050.1002649971

0.37143021850.28931646790.19365040890.054126591

-0.03008794070.4173440515-0.1136733044-0.2686142537

Agree

Disagree

Useful

Risky

Morally acceptable

Encourage

Sheet2

usefulriskyacceptableencourage

genetic test1.32-0.200.961.02

medicines1.240.030.870.91

crops0.770.150.520.39

lab animals0.410.27-0.19-0.08

food0.200.510.10-0.12

xenotransplants0.200.55-0.38-0.25

europe96chart

1.3181960008-0.19759472280.96445138231.0236815338

1.24368018460.03315582660.87160798180.9138320603

0.77145696960.14615868990.52275113560.3948970163

0.41014742890.2681839823-0.19294432-0.0780372409

0.20414951540.51122400470.0989826208-0.119573606

0.19952299640.5462268938-0.3829370189-0.2528162936

useful

risky

acceptable

encourage

Application

European means

EUROPEAN ATTITUDES TO SEVEN APPLICATIONS OF BIOTECHNOLOGY: 1996

Sheet1

foodusefulriskyacceptableencourage

1.00 B-0.010.73-0.17-0.4

2.00 DK-0.20.91-0.57-0.75

3.00 D0.020.58-0.15-0.32

4.00 GR-0.731.11-0.98-1.05

5.00 I-0.180.78-0.14-0.37

6.00 E0.640.520.430.22

7.00 FR-0.331.05-0.37-0.79

8.00 IRL0.240.83-0.17-0.25

10.00 LUX-0.311.14-0.3-0.81

11.00 NL0.490.680.42-0.1

12.00 P0.030.67-0.11-0.13

13.00 UK0.070.62-0.37-0.49

16.00 FIN0.510.060.120.14

17.00 S-0.090.88-0.24-0.61

18.00 A-0.570.85-0.58-0.89

Europe-0.030.75-0.21-0.45

cropsusefulriskyacceptableencourage

1.00 B0.60.440.410.17

2.00 DK0.530.65-0.17-0.3

3.00 D0.490.150.320.15

4.00 GR0.030.61-0.45-0.36

5.00 I0.610.290.420.36

6.00 E1.130.130.820.77

7.00 FR0.30.91-0.02-0.31

8.00 IRL0.530.73-0.06-0.08

10.00 LUX-0.011.05-0.1-0.53

11.00 NL0.810.650.510.24

12.00 P0.710.230.510.51

13.00 UK0.350.44-0.14-0.19

16.00 FIN0.88-0.140.530.49

17.00 S0.450.570.15-0.17

18.00 A-0.260.72-0.42-0.69

Europe0.490.480.160

medicines

usefulriskyacceptableencourage

1.00 B1.070.580.60.66

2.00 DK1.440.20.910.95

3.00 D1.08-0.050.760.84

4.00 GR0.730.410.130.3

5.00 I1.070.320.650.81

6.00 E1.420.050.941.09

7.00 FR1.080.790.60.62

8.00 IRL1.110.60.380.56

10.00 LUX0.990.870.770.73

11.00 NL1.30.510.910.89

12.00 P1.040.310.710.83

13.00 UK1.210.240.620.77

16.00 FIN1.02-0.20.560.63

17.00 S1.230.130.940.83

18.00 A0.750.520.460.35

Europe1.10.330.670.72

clone animals

usefulriskyacceptableencourage

1.00 B0.440.55-0.01-0.04

2.00 DK0.550.66-0.17-0.14

3.00 D-0.010.51-0.3-0.3

4.00 GR-0.270.9-0.79-0.68

5.00 I0.070.58-0.36-0.23

6.00 E0.840.330.340.39

7.00 FR0.040.98-0.36-0.38

8.00 IRL0.510.82-0.25-0.2

10.00 LUX0.110.96-0.18-0.23

11.00 NL0.310.760.08-0.07

12.00 P0.230.61-0.140.02

13.00 UK0.260.45-0.24-0.19

16.00 FIN0.410.25-0.030

17.00 S0.160.67-0.18-0.34

18.00 A-0.130.73-0.33-0.42

Europe0.220.64-0.2-0.2

clone humans

usefulriskyacceptableencourage

1.00 B0.960.720.450.5

2.00 DK1.050.480.50.56

3.00 D0.550.370.20.25

4.00 GR0.360.71-0.4-0.17

5.00 I0.980.590.410.66

6.00 E1.350.220.831.02

7.00 FR1.10.860.50.65

8.00 IRL0.980.78-0.040.27

10.00 LUX0.750.940.370.43

11.00 NL0.820.760.540.54

12.00 P1.290.310.921.03

13.00 UK1.050.40.30.47

16.00 FIN0.810.070.270.39

17.00 S0.810.510.520.41

18.00 A0.440.690.150.14

Europe0.880.550.370.46

gentest

usefulriskyacceptableencourage

1.00 B1.220.410.830.83

2.00 DK1.44-0.160.890.98

3.00 D1.08-0.240.80.83

4.00 GR1.33-0.531.071.15

5.00 I1.350.110.931.11

6.00 E1.4-0.181.071.23

7.00 FR1.470.261.011.14

8.00 IRL1.390.30.750.92

10.00 LUX0.960.690.680.71

11.00 NL1.420.161.121.06

12.00 P1.29-0.051.011.18

13.00 UK1.33-0.010.760.9

16.00 FIN1.25-0.560.840.91

17.00 S1.25-0.040.930.81

18.00 A0.710.440.460.41

Europe1.270.010.890.95

bacteria

usefulriskyacceptableencourage

1.00 B0.880.430.60.47

2.00 DK1.310.380.70.71

3.00 D1.17-0.170.930.95

4.00 GR0.620.040.250.29

5.00 I0.970.330.790.77UseRiskAcceptableEncourage

6.00 E1.220.060.971.021Genetic test1.26-0.040.890.96

7.00 FR1.030.670.630.622Medicines1.130.270.720.78

8.00 IRL1.210.430.610.723Bio-remediation0.990.230.670.65

10.00 LUX0.540.70.390.294Clone human cells0.840.520.320.43

11.00 NL1.310.520.980.935Crops0.500.460.200.05

12.00 P0.970.250.760.836Clone animals0.180.61-0.22-0.23

13.00 UK1.10.050.550.657Food0.030.73-0.14-0.37

16.00 FIN1.08-0.180.80.8

17.00 S0.60.440.410.2

18.00 A0.640.440.530.3

Europe0.990.280.680.642002

Statistics

USEGEN useful genetic testsRISGEN risky genetic testsMORGEN morally acceptable genetic testsENCGEN encourage genetic testsUSEXEN useful xenoRISXEN risky xenoMORXEN morally acceptable xenoENCXEN encourage xenoUSEFOO useful foodRISFOO risky foodMORFOO morally acceptable foodENCFOO encourage foodUSECRO useful cropsRISCRO risky cropsMORCRO morally acceptable cropsENCCRO encourage cropsUSEENZ useful enzymesRISENZ risky enzymesMORENZ morally acceptable enzymesENCENZ encourage enzymesUSECLH useful clone human cellsRISCLH risky clone human cellsMORCLH morally acceptable clone human cellsENCCLH encourage clone human cells

usefulriskyacceptableencourageNValid6026.72213948585554.31986049465759.86023777585666.44526054925794.77007012245626.02720467525621.10751712265442.15218266685737.69811395145575.71546217115554.38393891465469.13028686155632.70791791445410.41189030285484.62674824085305.04836759485207.45600358084914.29040769475085.89661919634950.59800120466059.90910448895655.91020645225780.26562131415678.2359888497

Genetic test1.270.010.890.95Missing8573.07020903279045.47248802398839.93211074278933.34708796928805.0222783968973.76514384328978.68483139589157.64016585168862.0942345679024.07688634739045.40840960389130.66206165698967.0844306049189.38045821569115.16560027759294.74398092369392.33634493769685.50194082369513.89572932219649.19434731388539.88324402958943.88214206628819.52672720438921.5563596687

Medicines1.10.330.670.72Mean

Bio-remediation0.990.280.680.64Std. Deviation0.82289194151.03735526140.93572560080.95825489721.04243781541.00239338991.06112695341.09488115051.10842564861.02132377311.06579698991.09546962930.99484223290.98502547241.02614277811.07076972371.02658834111.01077144381.00682693141.06225621990.94576542090.99171499790.99660381641.0163565312

Clone human cells0.880.550.370.46

Crops0.490.480.160UseRiskAcceptableEncourageUsefulRiskyMorally acceptableEncourage

Clone animals0.220.64-0.2-0.2Genetic test3.372.533.043.10Genetic test0.86789474510.02553600720.5416902110.5993294196

Food-0.030.75-0.21-0.45Clone human cells3.222.862.792.92Clone human cells0.71969517720.35828444370.28668278130.4217100103

Enzymes2.962.602.802.71Enzymes0.46495009630.09588906620.29876061930.2145023388

Xenotransplantation2.932.902.522.60Xenotransplantation0.431858720.4038858890.02126258050.1002649971

Crops2.872.792.692.55Crops0.37143021850.28931646790.19365040890.054126591

Food2.472.922.392.23Food-0.03008794070.4173440515-0.1136733044-0.2686142537

2.5

Chart1

1.370.041.011.07

1.28-0.20.880.92

0.88-0.260.550.42

0.21-0.48-0.38-0.3

0.42-0.540.22-0.02

0.19-0.76-0.46-0.36

useful

risky

morally aceptable

encourage

Application

UK means

FIGURE : UK ATTITUDES TO SIX APPLICATIONS OF BIOTECHNOLOGY

country means

Mean scores for Q10, for all countries

The Eurobarometer

Useful FoodUseful Crop PlantsUseful MedicinesUseful Animal LabsUseful TransplantsUseful Genetic TestingRisky FoodRisky Crop PlantsRisky MedicinesRisky Animal LabsRisky TransplantsRisky Genetic TestingAcceptable FoodAcceptable Crop PlantsAcceptable MedicinesAcceptable Animal LabsAcceptable TransplantsAcceptable Genetic TestingEncouraged FoodEncouraged Crop PlantsEncouraged MedicinesEncourged Animal LabsEncouraged TransplantsEncouraged Genetic Testing

B0.280.861.200.330.341.21-0.230.050.02-0.26-0.510.110.300.740.95-0.25-0.210.910.100.610.96-0.17-0.110.91

DK-0.090.701.420.880.271.29-0.64-0.440.250.05-0.390.33-0.280.170.99-0.22-0.450.84-0.64-0.030.98-0.11-0.370.77

D0.160.490.91-0.05-0.020.87-0.51-0.050.00-0.22-0.360.20-0.070.250.56-0.61-0.590.52-0.170.150.61-0.52-0.480.56

GR0.020.721.030.540.351.55-0.590.080.25-0.08-0.370.97-0.170.480.720.05-0.251.39-0.150.480.810.25-0.031.47

I0.060.891.090.490.131.41-0.50-0.02-0.05-0.40-0.680.150.200.710.77-0.15-0.401.05-0.040.660.840.10-0.231.19

E0.610.731.130.680.811.20-0.22-0.08-0.12-0.24-0.350.060.340.550.710.110.140.760.360.470.820.250.370.85

FR-0.010.751.260.640.361.38-0.61-0.21-0.26-0.35-0.600.120.100.540.84-0.03-0.271.02-0.260.330.930.17-0.091.16

IRL0.460.741.010.31-0.041.18-0.38-0.14-0.09-0.22-0.52-0.030.270.480.67-0.19-0.540.780.100.360.71-0.10-0.420.84

LUX0.110.461.170.370.271.09-0.39-0.260.240.05-0.140.270.050.280.80-0.10-0.170.72-0.190.090.87-0.00-0.130.83

NL0.440.911.320.05-0.101.30-0.70-0.36-0.58-0.51-0.73-0.300.400.610.86-0.13-0.300.900.080.430.82-0.24-0.350.84

P0.390.891.140.850.481.30-0.52-0.16-0.33-0.47-0.72-0.230.340.750.800.29-0.100.960.240.760.890.520.171.10

UK0.420.881.280.210.191.37-0.54-0.26-0.20-0.48-0.760.040.220.550.88-0.38-0.461.01-0.020.420.92-0.30-0.361.07

NO-0.170.100.810.20-0.310.68-0.54-0.41-0.18-0.19-0.58-0.03-0.28-0.100.42-0.13-0.530.32-0.49-0.220.49-0.12-0.510.31

FIN0.661.141.210.540.061.330.160.460.490.11-0.250.700.350.780.79-0.12-0.500.930.400.820.920.08-0.301.02

S-0.370.431.23-0.13-0.041.19-0.66-0.240.02-0.29-0.380.10-0.240.361.02-0.38-0.320.91-0.570.130.88-0.47-0.340.84

A-0.42-0.230.61-0.17-0.360.38-0.40-0.300.04-0.06-0.170.07-0.54-0.430.20-0.43-0.530.15-0.83-0.640.14-0.46-0.560.16

CH-0.160.340.990.02-0.220.910.610.310.200.340.67-0.16-0.130.170.64-0.56-0.760.58-0.48-0.150.51-0.58-0.760.48

EU150.20.721.120.330.211.21-0.49-0.13-0.1-0.32-0.530.130.120.490.75-0.24-0.360.86-0.070.380.8-0.11-0.220.93

Useful FoodUseful Crop PlantsUseful MedicinesUseful Animal LabsUseful TransplantsUseful Genetic TestingRisky FoodRisky Crop PlantsRisky MedicinesRisky Animal LabsRisky TransplantsRisky Genetic TestingAcceptable FoodAcceptable Crop PlantsAcceptable MedicinesAcceptable Animal LabsAcceptable TransplantsAcceptable Genetic TestingEncouraged FoodEncouraged Crop PlantsEncouraged MedicinesEncourged Animal LabsEncouraged TransplantsEncouraged Genetic Testing

B0.280.861.200.330.341.21-0.230.050.02-0.26-0.510.110.300.740.95-0.25-0.210.910.100.610.96-0.17-0.110.91

NL0.440.911.320.05-0.101.30-0.70-0.36-0.58-0.51-0.73-0.300.400.610.86-0.13-0.300.900.080.430.82-0.24-0.350.84

UK

usefulriskymorally aceptableencourage

genetic testing1.370.041.011.07

medicines1.28-0.20.880.92

crops0.88-0.260.550.42

research animals0.21-0.48-0.38-0.3

food0.42-0.540.22-0.02

transplantations0.19-0.76-0.46-0.36

NL

usefulriskymorally aceptableencourage

genetic testing1.3-0.30.900.84

medicines1.32-0.580.860.82

crops0.91-0.360.610.43

research animals0.05-0.51-0.13-0.24

food0.44-0.70.400.08

transplantations-0.1-0.73-0.30-0.35

FIN

usefulriskymorally aceptableencourage

genetic testing1.130.70.931.02

medicines1.210.490.790.92

crops1.140.460.780.82

research animals0.540.11-0.120.08

food0.660.160.350.4

transplantations0.06-0.25-0.50-0.3

CH

usefulriskymorally aceptableencourage

medicines0.990.20.640.51

genetic testing0.91-0.160.580.48

crops0.340.310.17-0.15

food-0.160.61-0.13-0.48

research animals0.020.34-0.56-0.58

transplantations-0.220.67-0.76-0.76

Support and opposition for six applications of biotechnology in 15 countries

Sheet1

Genetic testsClone human cellsEnzymesXenoCropsFood

Spain++++++++++

Portugal++++++++

Ireland+++++++

Belgium++++++-

Sweden++++++--

Denmark+++++--

UK++++++-

Finland++++-++

Luxembourg++++++---

Germany+++++-

Italy++++++--

Netherlands+++++-

France+++-+---

Greece++++----

Austria+++---

++Strong support-Weak opposition

+Weak support--Strong opposition

Sheet2

Sheet3

WHITE BIOTECHCLEAN BIOPROCESSESRAW MATERIALS/WASTE

THE EUROPEAN KNOWLEDGE-BASED BIOECONOMY

SUSTAINABLE MANAGEMENT OF BIOLOGICAL RESOURCES(LAND, FOREST, MARINE)

SAFE HEALTHY & DIVERSE FOOD SUPPLYFork to Farm

CONSUMER CHOICE

BIOBASEDMATERIALSFOR HEALTHINDUSTRY& ENERGY

GREEN / BLUE BIOTECHOPTIMISED RAW MATERIALS

PRODUCTION

PROCESSING

TRACEABILITY SYSTEMSADVANCED FOOD TECHNOLOGIES

LOW INPUT FARMING - BIODIVERSITY ANIMAL HEALTH - RURAL DEVT.

NUTRITION (nutrigenomics) - PATHOGENS CONTAMINANTS - ALLERGENS

STABILITY - BIODEGRADABILITY FUNCTIONALITY (Chirality)

Keep in touch with research! General information - http://europa.eu.int General information on research - http://europa.eu.int/comm/research Information on research programmes - http://www.cordis.lu Info requests - research@cec.eu.int

White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

Biology has changed.One of the most striking examples of current biological sciences is the amount and volume of experimental data which is being generated through national and International efforts. This has changed the way we do biology.The amount of genetic information available is doubling every 2 years. It is now much more quantitative. It is now much more computationally intensive. Access to this information and being able to interrogate biological systems is therefore essential.Also rasied the bar in terms of exploitation.Each genome that has been sequenced has fundamentally changed the science of that organism.Vital that the school particapates, contributes and benefits from this effort.White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

The European Commission responded by proposing in January 2002 a European strategy for Life Science and Biotechnology that aims to develop sustainable and responsible policies for the development of these technologies.

White Biotechnology is the application of natures toolset to industrial production.

Industrial biotechnology allows the increasing use of renewable raw materials and helps to make industrial processes more sustainable (EuropaBio 2005)

Six applications genetic testing for inherited diseases; cloning human cells and tissue for diseases like Parkinsons: industrial enzymes for detergents, xenotransplants adding human genes to animals such as pigs for heart transplantation; GM crops resistance to insect and GM food higher protein, keep longer or change tasteFor each application respondents asked agree or disagree. useful for society, risky for society, morally acceptable and should be encouragedIn figure zero is the mid point between agreement and disagreement ie above the line is agree useful, risky, morally acceptable and encourage, below the line not useful, not risky, morally unacceptable and not encourage.Solid support for Genetic testing, support of cloning human cells (even though seen as risky); enzymes supported; xenotransplantation less useful and more risky than other medical applications but still overall support. Interesting contrasts between GM crops and foods. Crops seen as useful but risky, food not useful and more risky. GM crops not opposed while GM foods widely rejected. EU member states ranked in order of support over the six applications and the applications ranked left to right by level of support.Perhaps a surprising level of support across Europe for cloning human cells and tissues. Underlines general support for medical applications.At the other extreme and in the context of 2001/18/EC some national discussions about commercial exploitation of GM crops will face a sceptical public. With the exception of Belgium, all the countries that called for the continuation of the de facto moratorium (FR,It, Gr, DK, A and Lux) have publics that on the average are opposed to GM crops.GM foods still an uphill struggle but survey conducted before wide publicity of the decisions on labelling.